This is a synthetic peptide designed for use in combination with anti-ESRRG antibody (Catalog #: ARP45602_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
ESRRG
(Estrogen-Related Receptor gamma (ESRRG))
Hintergrund
ERRs, which are coexpressed with ERs in prostatic cells, could regulate cell growth and modulate ER-mediated pathways via interference on ERalpha transcription in prostatic cells. Not only PNRC2 but also the corepressor TLE1 functioned as ERRgamma coactivator in a reporter gene analysis. Transcriptional activation by ERR3 can be ligand-independent.
Alias Symbols: DKFZp781L1617, ERR3, FLJ16023, KIAA0832, NR3B3, ERRgamma
Protein Interaction Partner: ARHGEF15,CALM1,DAXX,DUT,ESRRA,NCOA1,NR0B2,NRIP1,PNRC1,PNRC2,PPARGC1A,PPARGC1B,PROX1,ESRRG,HGS,NCOA1